Table 3 Logistic regression of participants ordering a majority of pharmacologic treatment, non-pharmacologic treatment, and monitoring/follow-up

0.56

0.36

0.89

0.014

0.53

0.27

1.06

0.074

1.00

0.63

1.59

0.999

0.73

0.45

1.19

0.211

2.18

1.32

3.62

0.003

2.04

0.73

5.72

0.174

0.47

0.21

1.06

0.070

1.14

0.61

2.14

0.680

1.32

0.73

2.38

0.367

0.85

0.28

2.55

0.771

0.84

0.36

1.98

0.689

0.15

0.08

0.25

0.000

0.82

0.62

1.09

0.174

0.70

0.49

1.01

0.056

0.98

0.75

1.28

0.884

0.81

0.61

1.06

0.122

1.15

0.81

1.65

0.432

1.81

0.89

3.69

0.101

0.48

0.31

0.74

0.001

0.87

0.58

1.29

0.476

1.14

0.78

1.66

0.500

4.12

2.32

7.31

0.000

2.62

1.52

4.52

0.001

0.60

0.42

0.85

0.004

0.94

0.70

1.26

0.674

0.72

0.50

1.05

0.085

0.64

0.48

0.85

0.002

0.78

0.59

1.03

0.084

1.68

1.16

2.42

0.006

1.47

0.69

3.14

0.322

1.61

1.04

2.49

0.032

1.71

1.11

2.64

0.015

1.05

0.68

1.64

0.821

2.38

1.31

4.31

0.004

3.52

1.94

6.39

0.000

0.31

0.21

0.46

0.000